Labdaros ir paramos fondas Ateities biomedicinos fondas - financials and debts
Company age: 4 y. 9 mo.
Company finances
|
EUR
|
2021
From: 2021-12-20
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 0 | 190,000 | 400,945 | 1,010,309 | 564,797 |
| Profit before tax | - | -132,782 | -30,891 | 0 | 0 |
| Net profit | - | -132,782 | -30,891 | 0 | 0 |
| Equity | 0 | 17,218 | 36,327 | 36,327 | 36,327 |
| Liabilities | 0 | 3,549 | 18,905 | 16,171 | 14,586 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 |
| Current assets | 0 | 20,767 | 254,287 | 83,579 | 70,026 |
| Total assets | 0 | 20,767 | 254,287 | 83,579 | 70,026 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 11,240 | 24,665 | 25,394 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | +111.0% | +152.0% | -44.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | -639.4% | -12.1% | 0.0% | 0.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | -771.2% | -85.0% | 0.0% | 0.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -69.9% | -7.7% | 0.0% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -69.9% | -7.7% | 0.0% | 0.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.2 | 0.5 | 0.4 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 190,000 | 400,945 | 1,010,309 | 564,797 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-05-02 | 2023-05-07 | 0.03 |
| 2023-04-26 | 2023-04-28 | 0.03 |
| 2023-02-17 | 2023-03-07 | 4.00 |
| 2022-11-21 | 2022-12-06 | 1.66 |
| 2022-11-17 | 2022-11-18 | 1.66 |
| 2022-10-28 | 2022-11-07 | 1.66 |
VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-30 | 2026-02-16 | 1.33 |
| 2026-01-27 | 2026-01-29 | 0.22 |
| 2026-01-22 | 2026-01-26 | 1464.11 |
| 2026-01-01 | 2026-01-21 | 0.13 |
| 2025-11-28 | 2025-12-22 | 0.15 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Labdaros ir paramos fondas Ateities biomedicinos fondas (code 305959325) is an Other legal entity operating in other social work activities without accommodation n.e.c. In 2025, the latest financial year, revenue amounted to EUR 564.8K, down 44.1% year on year, but still 40.9% above the 2023 level of EUR 400.9K. The company reported a net loss of EUR 30.9K in 2023, with a profit margin of -7.7%; no net profit figure is provided for 2024 or 2025. The revenue trajectory shows a strong jump in 2024 to EUR 1.01M, followed by a decline in 2025. The balance sheet has remained relatively small: total assets decreased from EUR 254.3K in 2023 to EUR 70.0K in 2025, while equity stayed at EUR 36.3K and liabilities eased to EUR 14.6K. Latest ratios indicate an equity ratio of 51.9%, debt-to-equity of 0.40 and asset turnover of 8.07x. Revenue per employee in 2025 was EUR 564.8K.